Oncolytic virotherapy is an effective cancer treatment using a special viruses, capable of finding and destroying malignant tumour cells in the body. Rigvir is the first registrated and still the one and only genetically unmodified virus available worldwide.
More information: www.rigvir.com
After being administered, the virus finds and infects malignant tumour cells in a process called oncotropism. The virus replicates itself in the cells of a malignant tumour destroying them in a process called oncolysis. Viruses not only destroy cancer cells but also activate the body’s natural immune system, which also targets the malignant cells.
How virotherapy works
The goal of virotherapy, not unlike that of radiation therapy and chemotherapy, is to destroy cancer cells, but virotherapy has several distinct advantages:
Virotherapy destroys tumour cells selectively without affecting the healthy cells of the body.
Virotherapy stimulates the body’s natural defence mechanisms by activating the immune system, which is often supressed by other treatment methods.
Virotherapy can be used against tumours that don’t respond well to radiation or chemotherapy, such as melanomas.
Virotherapy can be used at various stages throughout the treatment process: before or after surgery and also between radiation or chemotherapy treatments.
Virotherapy is recognised as a safe and efficient cancer treatment method.
← Go back
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)
© 2019 International Virotherapy Center Limited. All Rights Reserved
Ltd State of Well (Reg.Nr. 40203172199) on a base of Licence and Cooperation Agreement (No. IVC-SW-02.01.2019), signed January 2nd, 2019 is legally responsible for the content of the website www.virotherapy.eu